文献速递生殖医学

宫内人工授精后盆腔炎性疾病的风险:一项系统综述

Risk of pelvic inflammatory disease after intrauterine insemination: a systematic review.
PubMed 文献 · Reprod Biomed Online · 2017-11-24

该系统综述通过检索宫内人工授精登记系统、已发表的荟萃分析和前瞻性随机试验,评估宫内人工授精后盆腔炎性疾病的发生率。两个符合纳入标准的登记系统共365874个周期,报告57例盆腔炎性疾病,发生率为0.16/1000(95%CI 0.2至0.3/1000)。夫精周期发生率(0.21/1000,28/135839)高于供精周期(0.03/1000,1/33712)(P<0.05;OR 6.95)。19项荟萃分析(包含156项试验,共43048个周期)和17项前瞻性临床试验(共4968个周期)均未报告盆腔炎性疾病病例。作者认为,除非存在相关风险因素,否则不应推荐抗生素预防。

要点

  • 宫内人工授精后临床盆腔炎性疾病报告发生率低,为0.16/1000(95%CI 0.2至0.3/1000)。
  • 夫精周期盆腔炎性疾病发生率(0.21/1000)高于供精周期(0.03/1000)(P<0.05;OR 6.95)。
  • 作者认为,除非存在相关风险因素,否则不应推荐抗生素预防。

核心结论

  • 宫内人工授精后临床盆腔炎性疾病的报告发生率低(0.16/1000),约比育龄期女性一般人群报告的发生率高40%。
  • 作者认为,除非存在相关风险因素,否则不应推荐抗生素预防。

研究设计与样本

  • 系统综述,通过三种途径检索:宫内人工授精登记系统、已发表的荟萃分析、前瞻性随机试验。
  • 检索词为「IUI」「complications」「infection」和「PID」。
  • 识别出两个符合纳入标准的宫内人工授精登记系统,共365874个周期。
  • 检索到19项荟萃分析,包含156项试验,共43048个周期。
  • 识别出2013年至2014年发表的17项前瞻性临床试验,共4968个周期。

主要发现

  • 两个登记系统共报告57例盆腔炎性疾病病例,宫内人工授精后盆腔炎性疾病发生率为0.16/1000(95%CI 0.2至0.3/1000)。
  • 夫精周期盆腔炎性疾病发生率为0.21/1000(28/135839),供精周期为0.03/1000(1/33712)(P<0.05;OR 6.95)。
  • 19项荟萃分析(包含156项试验,共43048个周期)中未报告盆腔炎性疾病病例。
  • 17项前瞻性临床试验(共4968个周期)中未报告盆腔炎性疾病病例。
  • 作者指出,报告的宫内人工授精后临床盆腔炎性疾病发生率约比育龄期女性一般人群报告的发生率高40%。

关键数值与推荐

  • 宫内人工授精后盆腔炎性疾病发生率为0.16/1000(95%CI 0.2至0.3/1000)。
  • 夫精周期盆腔炎性疾病发生率为0.21/1000(28/135839),供精周期为0.03/1000(1/33712)(P<0.05;OR 6.95)。

临床怎么用

  • 作者认为,除非存在相关风险因素,否则不应推荐抗生素预防。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of this study was to ascertain the incidence of pelvic inflammatory disease (PID) after intrauterine insemination (IUI). A systematic review was conducted using three different approaches: a search of IUI registries; a search of published meta-analyses; and a search of prospective randomized trials. Search terms were 'IUI', 'complications', 'infection' and 'PID'. Two IUI registers were identified that met the inclusion criteria, totalling 365,874 cycles, with 57 PID cases being reported. The post-IUI PID rate was 0.16/1000 (95% CI 0.2 to 0.3/1000). The frequency was higher in husband sperm cycles (0.21/1000) (28/135,839) than in donor sperm cycles (0.03/1000) (1/33,712) (P < 0.05; OR 6.95). Nineteen meta-analyses were retrieved, which included 156 trials, totalling 43,048 cycles, with no PID case being reported. Seventeen prospective clinical trials published between 2013 and 2014 were identified, totalling 4968 cycles; no PID case was reported. The reported rate of post-IUI clinical PID is low (0.16/1000), about 40% higher than reported in the general population of women during their reproductive life. No antibiotic prophylaxis should be recommended unless there is an associated risk factor.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Matorras R, Rubio K, Iglesias M, et al. Risk of pelvic inflammatory disease after intrauterine insemination: a systematic review. Reprod Biomed Online. 2017. PMID: 29287941. doi:10.1016/j.rbmo.2017.11.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。